Biocon’s arm collaborates with Baxter International to establish Global Research Center

05 Feb 2014 Evaluate

Syngene, a wholly owned subsidiary of Biocon, and Baxter International, a leading global pharmaceutical company have collaborated to establish the Baxter Global Research Center at Syngene, in Bangalore. The Center was inaugurated by Ghulam Nabi Azad, the Minister of Health and Family Welfare, Government of India.

The Baxter Global Research Center (BGRC) at Syngene, is a part of Baxter's global strategy of building R&D collaborations with strategic partners. This collaboration will support Baxter in the Research and Development of medical products and devices to serve patients both in India and around the world. The Syngene team, working closely with Baxter scientists, will engage in a wide range of R&D activities centered on product and analytical development and pre-clinical evaluation in parenteral nutrition and renal therapy.

Biocon is India’s largest and Asia's leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

390.40 0.15 (0.04%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×